2025-11-15T11:18:35-00:00 2024-12-31 223285732 ARTHUR P BULACAN & CO PC 350 RIVERDALE ROAD POMPTON LAKES NJ 07442 990 2024-01-01 921054959 SALIVADIRECT INC SALI 9296057711 396 MANSFIELD STREET New Haven CT 06511 Yasmine Ali Executive Director 9296057711 2025-11-15 false ARTHUR P BULACAN CPA P01433032 9738316446 2025-11-15 2024 2025-03-06 01:10:19Z Yasmine Ali 396 MANSFIELD New Haven CT 06511 1997931 false X www.salivadirect.com X 2022 CT TO ESTABLISH, OPERATE OR MAINTAIN LABORATORIES ENGAGED IN BIOSCIENTIFIC RESEARCH AND OTHER ACTIVITIES TO SUPPORT SURVEILLANCE TESTING THROUGH THE PERFORMANCE OF SALIVA BASED TESTING. 6 6 18 0 305616 64001 1284113 1929614 4316 0 1589729 1997931 190882 91000 0 333922 750598 0 100404 275179 812321 799983 1653919 789746 344012 1238539 1435542 448793 301784 789746 1133758 TO ESTABLISH, OPERATE OR MAINTAIN LABORATORIES ENGAGED IN BIOSCIENTIFIC RESEARCH AND OTHER ACTIVITIES THAT SUPPORT SURVEILLANCE TESTING THAT ADDRESS KEY GLOBAL PUBLIC ISSUES, TO PROMOTE, SUPPORT AND FURTHER EQUITABLE SURVEILLANCE AND SALIVA-BASED TESTING WITHIN NATIONS AND GLOBALLY, TO DEVELOP AND SUPPORT RELATED SCIENTIFIC RESEARCH AND ASSAYS. false false 91000 A key accomplishment has been the successful implementation of SalivaDirect testing in Malawi. The team conducted comprehensive training for local laboratory scientists, transferring knowledge and skills to build local capacity. They have made substantial progress in comparing the performance of saliva samples to paired nasopharyngeal swabs for detecting respiratory viruses. Preliminary results show substantial agreement for SARS-CoV-2, RSV, and Influenza B detection between the two sample types, with saliva detecting significantly more Influenza A cases. 1137125 Initiation of Saliva Direct Inc Lab Network Sustainability Plan through Federal Drug Administration FDA engagement in preparing the De Novo authorization of the SARS-CoV-2 assay, expanding assay development to include SARs-CoV-2, influenza A/B and RSV in a multiplex PCR assay, and launching mobile testing accross New Haven by partnering with 22 community organizations. The mobile testing was deployed to 123 events across Connecticut, providing 1,428 free SARS-CoV-2 tests excedding the goal of 400 tests with high engagement from uninsured and underserved communities. The key findings indicated that 74 of participants found it easy to access the van and 75 were comfortable with using the services demonstrating the effectiveness of mobile testing in overcoming barriers such as transportation, access to healthcare and showing of strong interest in expanding mobile health services to include health screenings. 1228125 true false false false false false false false false false true false false false false false false false false false true true false false false false false false false true false false false false false false false false false false false false false false false false false true 5 0 18 true false false false false false false false false false false false false X 6 6 false false false false false false false true true false false true true true true false true true true false X YASMINE ALI 9296057711 396 Mansfield Street New Haven CT 06511 Yasmine Ali Executive Director 035.00 X 136958 0 22097 Brittany Choate Program Manager 035.00 X 107613 0 19638 Alexander Kitz Director of Science 035.00 X X 99045 0 15164 Laura Burke Regulatory and Compliance Manager 035.00 X 77275 0 21086 Victoria Hurley Marketing Manager 035.00 X 75346 0 13067 Russell Thomas Senior Business Associate 035.00 X 70577 0 14152 Robby Sikka Chairman of the Board 002.00 X X 0 0 0 Anne Wylie Director 002.00 X 0 0 0 Prem Premsrirut Director 002.00 X 0 0 0 Mostafa Analou Treasurer 002.00 X X 0 0 0 Shyam Saladi Secretary 002.00 X X 0 0 0 Avi Robbins Director 002.00 X 0 0 0 Lohahon Kadiri Director 002.00 X 0 0 0 566814 105204 3 false true false 64001 64001 Contract Revenue 1903694 1903694 Conference Sponsorship 25920 25920 1929614 4316 4316 1997931 1929614 4316 0 0 91000 91000 0 566814 425110 73686 68018 0 65388 49042 8500 7846 21807 16355 2835 2617 45441 34080 5908 5453 51148 38361 6649 6138 0 10448 10448 18000 18000 0 0 0 0 63922 11000 52922 0 0 0 0 0 105182 105182 0 0 3506 3506 15465 15465 OUTSIDE PRINTING AND MARKETING 58321 58321 CONSULTING AND OTHER FEES 537477 504758 22387 10332 0 1653919 1333209 220306 100404 169749 1373884 1064386 48885 17381 4608 4404 12773 1238539 1435542 13000 301784 435793 448793 301784 X 789746 1133758 789746 1133758 1238539 1435542 344012 X true X false X 1589729 1589729 1589729 1589729 1589729 1589729 1589729 1997931 3587660 1589729 1997931 3587660 3587660 0 0 0 0 1589729 1997931 3587660 X 0.00000 0.00000 false 17381 4608 12773 12773 Financial derivatives and other financial products Closely-held equity interests Federal income taxes true Sub-Saharan Africa Program Services The team conducted comprehensive training for local laboratory scientists, transferring knowledge and skills to build local capacity. They have made substantial progress in comparing the performance of saliva samples to paired nasopharyngeal swabs for detecting respiratory viruses. Preliminary results show substantial agreement for SARS-CoV-2, RSV, and Influenza B detection between the two sample types, with saliva detecting significantly more Influenza A cases. 91000 91000 91000 Sub-Saharan Africa Advocacy and Education 91000 Wire FMV 1 false false false false false false Part I Line 1 Monitoring through evaluation of the results and program objectives true X X X false false false false false false false false false Yasmine Ali Executive Director 136958 5579 16518 159055 Form 990, Part I, Section 2, Line 1 Monitoring through reporting and evaluation of program results Form 990, Part VI, Section B, Line 11b After the return is prepared by externalaccountants, it is reviewed by the Executive Director. Additionally a copy of the return issent to the organizations legal counsel for review. The Executive director provides a copy ofthe Form 990 to members of the board prior to filing. Form 990, Part VI, Section B, Line 12c Every employee of Saliva Direct Inc is required annually to sign a form that ensures everyone is aware of and in compliance with Conflict of Interest Policy. In addition, every board member and officers annually completes a Conflict of Interest disclosure statement disclosing the facts relating to any actual or potentialfinancial interest or stating that he or she has no reportable financial interest that wouldconstitute a conflict or potential conflict of interest and acknowledge that he or she reviewed, understood and agreed to comply with the conflict on Interest policy. Any board member or officer with a conflict or potential conflict of interest to disclose the existence and all material facts regarding any interest in a transaction or matter being considered by the board and to recuse himself or herself from the meeting in which the transaction or matter is discussed and voted upon Form 990, Part VI, Section B, Line 15a The Board of Directors has the responsibility and authority to determine the nature and amount of compensation to included in the Executive Directors contract taking into consideration compensation from comparable organization in the area where the organization operates